Damage potential
New cancer drug combo treats autoimmune disease
Although cancer drugs have proven effective in treating autoimmune diseases, their intolerable long-term toxicity has discouraged new players from exploring their potential. A group at University of Cincinnati has discovered a new combination that kills activated autoimmune lymphocytes, while sparing cells typically crippled by chemotherapy.
Because standard treatment involves blanket immune suppression, the goal is to produce a system for achieving antigen-specific immune suppression that is both potent and selective. ...